The functions and regulation of the PTEN tumour suppressor
The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Abstract
The importance of the physiological function of phosphatase and tensin homologue (PTEN) is illustrated by its frequent disruption in cancer. By suppressing the phosphoinositide 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway through its lipid phosphatase activity, PTEN governs a plethora of cellular processes including survival, proliferation, energy metabolism and cellular architecture. Consequently, mechanisms regulating PTEN expression and function, including transcriptional regulation, post-transcriptional regulation by non-coding RNAs, post-translational modifications and protein-protein interactions, are all altered in cancer. The repertoire of PTEN functions has recently been expanded to include phosphatase-independent activities and crucial functions within the nucleus. Our increasing knowledge of PTEN and pathologies in which its function is altered will undoubtedly inform the rational design of novel therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the majority of prostate cancer patients at presentation have lost one allele of PTEN while maintaining intact TP53; whereas TP53 mutations and the complete loss of PTEN are both associated with advanced stage prostate cancer 153,154”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [154]
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Salmena, L., Poliseno, L., Tay, Y., Kats, L., & Pandolfi, P. P. (2011) · Cell · doi:10.1016/j.cell.2011.07.014 · Cited by 7,262
Self-citationAKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
Cited by
Items 701–800 of 1,010
Mechanism of PRL2 phosphatase-mediated PTEN degradation and tumorigenesis
Li, Q., Bai, Y., Lyle, L. T., Yu, G., Amarasinghe, O., Meke, F. N., Carlock, C., & Zhang, Z. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002964117 · Cited by 38
Kapucu, A. (2020) · Biotechnic & Histochemistry · doi:10.1080/10520295.2020.1808702 · Cited by 37
NOTCH and EZH2 collaborate to repress PTEN expression in breast cancer
Pappas, K., Martin, T. C., Wolfe, A. L., Nguyen, C. B., Su, T., Jin, J. J., Hibshoosh, H. H., & Parsons, R. E. (2021) · Communications Biology · doi:10.1038/s42003-021-01825-8 · Cited by 41
Zhu, X., Li, R., Wang, C., Zhou, S., Fan, Y., Ma, S., Gao, D., Gai, N., & Yang, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.661184 · Cited by 37
Pulido, R., Stoker, A. W., & Hendriks, W. J. A. J. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt347 · Cited by 37
Liu, Y., Zhao, R., Wei, Y., Li, M., Wang, H., Niu, W., Zhou, Y., Qiu, Y., Fan, S., Zhan, Y., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0734-2 · Cited by 42
Fragoso, R., & Barata, J. T. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.05.005 · Cited by 38
Yuen, J. W.-F., Chung, G. T., Lun, S. W., Cheung, C. C., To, K., & Lo, K. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105163 · Cited by 40
The Role of PTEN in Myeloid Malignancies
Morotti, A., Panuzzo, C., Crivellaro, S., Carrà, G., Torti, D., Guerrasio, A., & Saglio, G. N. (2015) · Hematology Reports · doi:10.4081/hr.2015.6027 · Cited by 40
Mahon, R. N., & Hafner, R. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ621 · Cited by 40
PHLPP1 mediates melanoma metastasis suppression through repressing AKT2 activation
Yu, Y., Dai, M., Lu, A., Yu, E., & Merlino, G. T. (2018) · Oncogene · doi:10.1038/s41388-017-0061-7 · Cited by 38
Lin, C., Lin, C., Lin, H., Li, K., Kao, S., & Tsao, S. (2018) · Environmental Toxicology · doi:10.1002/tox.22685 · Cited by 39
Kim, G., & Siddiqui, A. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00581-3 · Cited by 40
Jiang, K., Yang, J., Song, C., He, F., Yang, L., & Li, X. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.56933 · Cited by 36
An alternative UPF1 isoform drives conditional remodeling of nonsense‐mediated mRNA decay
Fritz, S. E., Ranganathan, S., Wang, C. D., & Hogg, J. R. (2022) · The EMBO Journal · doi:10.15252/embj.2021108898 · Cited by 35
Akerlund, J., Getahun, A., & Cambier, J. C. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.06.007 · Cited by 36
Autoimmunity risk alleles: hotspots in B cell regulatory signaling pathways
Cambier, J. C. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69289 · Cited by 36
Inflammation-induced miR-802 promotes cell proliferation in cholesteatoma
Li, N., & Qin, Z. (2014) · Biotechnology Letters · doi:10.1007/s10529-014-1545-y · Cited by 36
Cadmium Selectively Induces MIP-2 and COX-2 Through PTEN-Mediated Akt Activation in RAW264.7 Cells
Huang, Y., Xia, M., Wang, H., Liu, X.-J., Hu, Y.-F., Chen, Y., Zhang, C., & Xu, D. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu013 · Cited by 36
RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes
Weinberg, M. A. (2016) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000354 · Cited by 39
Prostate OrganogenesisPreprint
Francis, J. C., & Swain, A. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030353 · Cited by 43
Liao, Y., Gui, Y., Li, Q., An, J., & Wang, D. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188998 · Cited by 43
The p53-Mdm2 Loop: A Critical Juncture of Stress Response
Levav-Cohen, Y., Goldberg, Z., Tan, K. H., Alsheich-Bartok, O., Zuckerman, V., Haupt, S., & Haupt, Y. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_9 · Cited by 42
Genetically engineered mouse models of PI3K signaling in breast cancer
Klarenbeek, S., van Miltenburg, M. H., & Jonkers, J. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.02.003 · Cited by 39
Molecular physiology of the tensin brotherhood of integrin adaptor proteins
Haynie, D. T. (2014) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.24560 · Cited by 35
He, L.-J., Yang, D.-L., Li, S., Zhang, Y.-J., Tang, Y., Lei, J., Frett, B., Lin, H., Li, H., Chen, Z., et al. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.06.010 · Cited by 35
Steinbach, N., Hasson, D., Mathur, D., Στρατικόπουλος, Η., Sachidanandam, R., Bernstein, E., & Parsons, R. E. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz272 · Cited by 42
Henriques, A. D., Machado‐Silva, W., Leite, R. E. P., Suemoto, C. K., Leite, K. R. M., Srougi, M., Pereira, A. C., Filho, W. J., & Nóbrega, O. D. T. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111352 · Cited by 47
Pathology-based Biomarkers Useful for Clinical Decisions in Melanoma
Torres-Cabala, C. A., Li-Ning-Tapia, E. M., & Hwu, W. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.09.008 · Cited by 39
Strategies to Overcome Failures in T-Cell Immunotherapies by Targeting PI3K-δ and –γ
Chandrasekaran, S., Funk, C. R., Kleber, T. J., Paulos, C. M., Shanmugam, M., & Waller, E. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.718621 · Cited by 37
The Role of RNA Methyltransferase METTL3 in Normal and Malignant Hematopoiesis
Wu, X., Wu, Y., & Gong, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.873903 · Cited by 36
Understanding the Tumor Suppressor PTEN in Chronic Alcoholism and Hepatocellular Carcinoma
Shearn, C. T., & Petersen, D. R. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-09614-8_10 · Cited by 37
Jin, H., Sun, Y. N., Wang, S., & Cheng, X. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140816040 · Cited by 35
Sushma, P. S., Jamil, K., Kumar, P. U., Satyanarayana, U., Ramakrishna, M., & Triveni, B. (2015) · Tumor Biology · doi:10.1007/s13277-015-4648-8 · Cited by 36
PTP1B promotes aggressiveness of breast cancer cells by regulating PTEN but not EMT
Liu, X., Chen, Q., Hu, X., Zhang, X.-C., Fu, T., Liu, Q., Liang, Y., Zhao, X., Zhang, X., Ping, Y., et al. (2016) · Tumor Biology · doi:10.1007/s13277-016-5245-1 · Cited by 37
CRISPR/Cas9: a historical and chemical biology perspective of targeted genome engineering
Singh, A., Chakraborty, D., & Maiti, S. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00197a · Cited by 35
An Insight on Novel Molecular Pathways in Metastatic Prostate Cancer: A Focus on DDR, MSI and AKT
Mollica, V., Marchetti, A., Rosellini, M., Nuvola, G., Rizzo, A., Santoni, M., Cimadamore, A., Montironi, R., & Massari, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413519 · Cited by 38
MTHFD2 reprograms macrophage polarization by inhibiting PTEN
Shang, M., Ni, L., Shan, X., Cui, Y., Hu, P., Ji, Z., Shen, L., Zhang, Y., Zhou, J., Chen, B., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112481 · Cited by 37
DNA aptamer-conjugated lipid nanoparticle for targeted PTEN mRNA delivery to prostate cancer cells
Lee, J. S., Kim, M., Jin, H., Kwak, M., Cho, E., Kim, K.-S., & Kim, D. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124519 · Cited by 41
Zhang, G., Yang, P., Guo, P.-D., Miele, L., Sarkar, F. H., Wang, Z. P., & Zhou, Q. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.03.001 · Cited by 36
NEDD4 Depletion Inhibits Hepatocellular Carcinoma Growth via Targeting PTEN
Hang, X., Zhu, S., Di, H., Wu, Z., Chu, K., Wang, J., Xin, H., Yu, G., Peng, H., Miao, X., et al. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000445667 · Cited by 35
Sun, J., Yan, J., Yuan, X., Yang, R., Dan, T., Wang, X., Kong, G., & Gao, S. (2016) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-016-0022-0 · Cited by 35
de Stephanis, L., Mangolini, A., Servello, M., Harris, P. C., Dell’Atti, L., Pinton, P., & Aguiari, G. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26473 · Cited by 34
Alternative polyadenylation confers PtenmRNAs stability and resistance to microRNAs
Thivierge, C., Tseng, H.-W., Mayya, V. K., Lussier, C. R., Gravel, S., & Duchaîne, T. F. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky666 · Cited by 37
“PTEN is a prominent negative regulator of the PI3K/Akt/mTOR signalling pathway (3,4).”
Barth, D. A., Drulă, R., Ott, L. F., Fabris, L., Slabý, O., Călin, G. A., & Pichler, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00828 · Cited by 34
Khan, M. M., Mohsen, M. T., Malik, M. Z., Bagabir, S. A., Alkhanani, M., Haque, S., Serajuddin, M., & Bharadwaj, M. (2022) · Genes · doi:10.3390/genes13040655 · Cited by 39
Walls, M., Baxi, S. M., Mehta, P. P., Liu, K. K. ‐., Zhu, J., Estrella, H., Li, C., Zientek, M. A., Zong, Q., Smeal, T., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1663 · Cited by 35
RetractedLiao, S., Ruiz, Y., Gulzar, H., Yelskaya, Z., Taouit, L. A., Houssou, M., Jaikaran, T., Schvarts, Y., Kozlitina, K., Basu-Roy, U., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171256 · Cited by 34
Zhang, Y., Qi, G., Yan, Y., Wang, C., Wang, Z., Jiang, C., Jiang, Z., Ma, T., Zhang, C., & Yan, Z. (2023) · The Journal of Gene Medicine · doi:10.1002/jgm.3510 · Cited by 34
Kukułowicz, J., Pietrzak-Lichwa, K. J., Klimończyk, K., Idlin, N., & Bajda, M. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.123.000886 · Cited by 37
BCR-ABL inactivates cytosolic PTEN through Casein Kinase II mediated tail phosphorylation
Morotti, A., Panuzzo, C., Crivellaro, S., Carrà, G., Fava, C., Guerrasio, A., Pandolfi, P. P., & Saglio, G. N. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1006970 · Cited by 34
Self-citationSHIP2 signaling in normal and pathological situations: Its impact on cell proliferation
Edimo, W. E., Schurmans, S., Roger, P. P., & Erneux, C. (2013) · Advances in Biological Regulation · doi:10.1016/j.jbior.2013.09.002 · Cited by 35
Lei, M., Xie, W., Sun, E., Sun, Y., Tian, D., Liu, C., Han, R., Li, N., Liu, M., Han, R., et al. (2015) · DNA and Cell Biology · doi:10.1089/dna.2015.2868 · Cited by 35
Geuna, E., Roda, D., Rafii, S., Jiménez, B., Capelán, M., Rihawi, K., Montemurro, F., Yap, T. A., Kaye, S. B., Bono, J. S. D., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.373 · Cited by 39
Tumor-suppressor NFκB2 p100 interacts with ERK2 and stabilizes PTEN mRNA via inhibition of miR-494
Wang, Y., Xu, J., Gao, G., Li, J., Huang, H., Jin, H., Zhu, J., Che, X., & Huang, C. (2015) · Oncogene · doi:10.1038/onc.2015.470 · Cited by 36
Padala, R. R., Karnawat, R., Viswanathan, S. B., Thakkar, A. V., & Das, A. B. (2017) · Molecular BioSystems · doi:10.1039/c6mb00786d · Cited by 33
Beyond regulation of pol III: Role of MAF1 in growth, metabolism, aging and cancer
Zhang, S., Li, X., Wang, H., & Zheng, X. F. S. (2018) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2018.01.019 · Cited by 37
Nan, H., Han, L., Ma, J., Yang, C., Su, R., & He, J. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.031 · Cited by 35
Saintigny, P., Mitani, Y., Pytynia, K. B., Ferrarotto, R., Roberts, D. B., Weber, R. S., Kies, M. S., Maity, S. N., Lin, S.-H., & El‐Naggar, A. K. (2018) · Cancer · doi:10.1002/cncr.31600 · Cited by 33
LNRLMI: Linear neighbour representation for predicting lncRNA‐miRNA interactions
Wong, L., Huang, Y., You, Z., Chen, Z., & Cao, M. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14583 · Cited by 33
Lv, X., Ying, H., Ma, X., Qiu, N., Wu, P., Yang, B., & Hu, Y. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.05.025 · Cited by 37
Epigallocatechin gallate inhibits HeLa cells by modulation of epigenetics and signaling pathways
Sundaram, M. K., Haque, S., Somvanshi, P., Bhardwaj, T., & Hussain, A. (2020) · 3 Biotech · doi:10.1007/s13205-020-02473-1 · Cited by 33
Han, D., Zhang, Q., Zhang, Y., Han, X., Guo, S., Teng, F., Yan, X., & Li, H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.594683 · Cited by 33
Liang, L., Huan, L., Wang, J., Wu, Y., Huang, S., & He, X. (2021) · Cell Discovery · doi:10.1038/s41421-021-00339-1 · Cited by 34
Yue, H.-W., Liu, J., Liu, P., Li, W., Chang, F., Miao, J., & Zhao, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.04.001 · Cited by 33
Xing, Y., Zhang, J., Wei, H., Zhang, H., Guan, Y., Wang, X., & Tong, X. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216665 · Cited by 34
Liu, D., Che, X., & Wu, G. (2024) · Biomarker Research · doi:10.1186/s40364-023-00545-x · Cited by 38
Mafi, A., Khoshnazar, S. M., Shahpar, A., Nabavi, N., Hedayati, N., Alimohammadi, M., Hashemi, M., Taheriazam, A., & Farahani, N. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155442 · Cited by 36
The Role of the PI3K/Akt/mTOR Axis in Head and Neck Squamous Cell Carcinoma
Jiang, Q., Xiao, J., Hsieh, Y.-C., Kumar, N. L., Han, L., Zou, Y., & Li, H. (2024) · Biomedicines · doi:10.3390/biomedicines12071610 · Cited by 222
“…of its remarkable correlation between hyperactivity and the evolution human tumors, the production of boosted tumor microvessels, and a rise in the invasive cancer Even though the Food and Drug Administration (FDA) has authorized several inhibitors, concerns about toxicity, sensitivity…”
BackgroundPTEN regulates natural killer cell trafficking in vivo
Leong, J. W., Schneider, S. E., Sullivan, R. P., Parikh, B. A., Anthony, B. A., Singh, A., Jewell, B. A., Schappe, T., Wagner, J. A., Link, D. C., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413886112 · Cited by 35
Johnston, S. B., & Raines, R. T. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00028 · Cited by 34
Muniyan, S., Ingersoll, M. A., Batra, S. K., & Lin, M. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.04.006 · Cited by 34
Zhang, D., Peihua, Z., Wang, W., Wang, X., LI, J., Sun, X., & ZHANG, L. (2015) · Oncology Reports · doi:10.3892/or.2015.4334 · Cited by 33
Mechanisms of Resistance to Immune Checkpoint Antibodies
Ramos, R. N., Piaggio, E., & Romano, E. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_11 · Cited by 34
EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer
Oldrini, B., Hsieh, W.-Y., Erdjument‐Bromage, H., Codega, P., Carro, M. S., Curiel‐García, Á., Campos, C., Pourmaleki, M., Grommes, C., Vivanco, I., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02185-w · Cited by 33
Liao, H., Huang, J., Lan, T., Wang, J., Zhu, B., Yuan, K., & Zeng, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-23647-1 · Cited by 31
Singh, S., Asal, R., & Bhagat, S. (2018) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36510 · Cited by 32
Grzywa, T. M., Klicka, K., Rak, B., Mehlich, D., Garbicz, F., Zieliński, G., Maksymowicz, M., Sajjad, E. A., & Wlodarski, P. K. (2019) · Endocrine · doi:10.1007/s12020-019-01960-7 · Cited by 34
The PTEN Tumor Suppressor Gene in Soft Tissue Sarcoma
Sioletic, S., & Scambia, G. (2019) · Cancers · doi:10.3390/cancers11081169 · Cited by 35
The Mechanisms Underlying PTEN Loss in Human Tumors Suggest Potential Therapeutic Opportunities
Chang, H., Cai, Z., & Roberts, T. M. (2019) · Biomolecules · doi:10.3390/biom9110713 · Cited by 37
Revisiting PI3-kinase signalling in angiogenesis
Kobialka, P., & Graupera, M. (2019) · Vascular Biology · doi:10.1530/vb-19-0025 · Cited by 37
Han, Y., Tian, Y., Wang, R., Fu, S., Jiang, J., Dong, J., Qin, M., Hou, Y., & Zhao, Y. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104197 · Cited by 34
Emerging roles of microRNAs in intestinal ischemia/reperfusion–induced injury: a review
Akbari, G. (2020) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-020-00772-y · Cited by 34
Cheng, C., Dong, Y., Ru, X., Xia, Y., & Ji, Y. (2020) · Cancer Gene Therapy · doi:10.1038/s41417-020-00263-8 · Cited by 32
The HECT family of E3 ubiquitin ligases and PTEN
Song, M. S., & Pandolfi, P. P. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.012 · Cited by 34
Self-citationEmerging roles of TRIM27 in cancer and other human diseases
Yu, C., Rao, D., Wang, T., Song, J., Zhang, L., & Huang, W. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1004429 · Cited by 40
PTEN–PDZ domain interactions: Binding of PTEN to PDZ domains of PTPN13
Sotelo, N. S., Schepens, J. T. G., Valiente, M., Hendriks, W. J. A. J., & Pulido, R. (2014) · Methods · doi:10.1016/j.ymeth.2014.10.017 · Cited by 40
The association of PTEN hypermethylation and breast cancer: a meta-analysis
Luo, S., Chen, J., & Mo, X. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s111684 · Cited by 32
Li, W., Chen, X., Yang, Y., Huang, H., Li, H.-D., Huang, C., Meng, X., & Li, J. (2016) · Toxicology · doi:10.1016/j.tox.2016.11.004 · Cited by 32
Alfieri, R. R., Giovannetti, E., Bonelli, M. A., & Cavazzoni, A. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00170 · Cited by 32
Assumpção, J. A. F., Magalhães, K. G., & Corrêa, J. R. (2017) · Cancer Cell International · doi:10.1186/s12935-017-0451-5 · Cited by 37
A Nonpump Function of Sodium Iodide Symporter in Thyroid Cancer via Cross-talk with PTEN Signaling
Fěng, F., Yehia, L., Ni, Y., Chang, Y. S., Jhiang, S. M., & Eng, C. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1954 · Cited by 36
The Yin and Yang of cancer genes
Bashyam, M. D., Animireddy, S., Bala, P., Naz, A., & George, S. A. (2019) · Gene · doi:10.1016/j.gene.2019.04.025 · Cited by 35
Rafting on the Plasma Membrane: Lipid Rafts in Signaling and Disease
Isik, O. A., & Cizmecioglu, O. (2023) · Advances in experimental medicine and biology · doi:10.1007/5584_2022_759 · Cited by 38
Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology
Chaudhuri, A., Kumar, D. N., Dehari, D., Patil, R., Singh, S. K., Kumar, D. K., & Agrawal, A. K. (2023) · Cancers · doi:10.3390/cancers15092661 · Cited by 32
“, tumor suppression and the hyperactivation of AKT, which furthers lead to cell proliferation, resistance to apoptosis, and the switching of p27 from tumor suppressor to an oncogene [84,85].”
BackgroundAmino acid-induced impairment of insulin sensitivity in healthy and obese rats is reversible
Jeganathan, S., Abdullahi, A., Zargar, S., Maeda, N., Riddell, M. C., & Adegoke, O. A. J. (2014) · Physiological Reports · doi:10.14814/phy2.12067 · Cited by 32
Phosphoinositide signaling in sperm development
Brill, J. A., Yildirim, S., & Fabian, L. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.06.010 · Cited by 32
Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids
Riemer, P., Rydenfelt, M., Marks, M., van Eunen, K., Thedieck, K., Herrmann, B. G., Blüthgen, N., Sers, C., & Morkel, M. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201610058 · Cited by 31
Eritja, N., Felip, I., Dosil, M. A., Vigezzi, L., Mirantes, C., Yeramian, A., Navaridas, R., Santacana, M., Llobet‐Navàs, D., Yoshimura, A., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.73 · Cited by 31
Divergent Activity of the Pseudogene PTENP1 in ER-Positive and Negative Breast Cancer
Yndestad, S., Austreid, E., Skaftnesmo, K. O., Lønning, P. E., & Eikesdal, H. P. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0207 · Cited by 31
Metadata
- Authors
- Song, M. S., Salmena, L., & Pandolfi, P. P.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Song, Min Sup
- Salmena, Leonardo
- Pandolfi, Pier Paolo
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2012-04-04
- Volume
- 13
- Issue
- 5
- Pages
- 283-296
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2017739035
- Cited by
- 1,926
- References
- 159
- Citations by year
- 2026: 50 · 2025: 81 · 2024: 85 · 2023: 100 · 2022: 124 · 2021: 113 · 2020: 147 · 2019: 155 · 2018: 172 · 2017: 183 · 2016: 167 · 2015: 182 · 2014: 199 · 2013: 136 · 2012: 31
- FWCI
- 15.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Canadian Institutes of Health Research
- National Cancer Institute (R01 CA-82328-09, R01CA082328)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- PTEN, phosphatase and tensin homologue, tumour suppressor, PI3K/AKT/mTOR pathway, lipid phosphatase activity, transcriptional regulation, non-coding RNA, post-translational modification, protein-protein interaction, cancer therapy, energy metabolism, cell proliferation
- MeSH terms
- Animals, Cell Nucleus, Gene Expression Regulation, Humans, Mutation, Neoplasms, Protein Conformation, Neoplastic Stem Cells, Signal Transduction, Tumor Suppressor Proteins, PTEN Phosphohydrolase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.